QA: DURECT CORP in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001082038_2023_DURECT_CORP.pdf

Logs

Graph

Absolute values for 0001082038, DURECT CORP

  xvar xval
0 AssetsCurrent 51,394,000
1 IntangibleAssetsNetIncludingGoodwill 6,169,000
2 PropertyPlantAndEquipmentNet 188,000
3 remainder_Assets 2,349,000
4 LiabilitiesCurrent 34,004,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,588,000
8 SellingGeneralAndAdministrativeExpense 15,915,000
9 ResearchAndDevelopmentExpense 36,862,000
10 remainder_Expenses 0
11 remainder_Revenues 19,283,000
12 remainder_NetIncome -251,000
13 remainder_ComprehensiveNetIncome -3,000
  yvar yval
0 Assets 60,100,000
1 Liabilities 34,004,000
2 Expenses 54,365,000
3 Revenues 19,283,000
4 StockholdersEquity 26,096,000
5 NetIncome -35,333,000
6 ComprehensiveNetIncome -35,334,500
7 BaseVar 84,003,000
8 EconomicCapitalRatio 0.203

Edgar->Model Mapping

Feature Distribution

Change over Time